Neoadjuvant CMV chemotherapy for muscle-invasive bladder cancer: a new treatment paradigm?
28 Apr 2011
A comparison of nephron-sparing surgery and radical nephrectomy in the treatment of renal cell carcinoma: Results of EORTC trial 30904
28 Apr 2011
Activities of EORTC Fellows as of April 2011
28 Apr 2011
Nephron-sparing surgery and radical nephrectomy compared in the treatment of renal cell carcinoma in EORTC trial 30904
28 Apr 2011
EORTC study evaluates HRQoL reporting
28 Apr 2011
Abstracts accepted for the 2011 ASCO Annual Meeting
28 Apr 2011
Sylatron™ receives FDA approval based on the EORTC 18991 trial
28 Apr 2011
Neoadjuvant CMV chemotherapy for muscle-invasive bladder cancer: a new treatment paradigm?
28 Apr 2011